Wildlife Health Market (2026 - 2033)

Wildlife Health Market Summary

The global wildlife health market size was valued at USD 2.7 billion in 2025 and is projected to grow from USD 2.9 billion in 2026 to USD 5.4 billion by 2033, at a CAGR of 9.1% from 2026 to 2033. North America market dominated, with a revenue share of 30.4% in 2025. Some of the factors driving the market growth are rising zoonotic disease surveillance and One Health preparedness programs, government funding for avian influenza preparedness and wildlife protection and expansion of wildlife rehabilitation centers, zoos, and specialized veterinary infrastructure.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Increasing zoonotic disease outbreaks and cross-species transmission risks are driving higher investment in wildlife health surveillance, diagnostics, and preventive care. Governments and international organizations are expanding One Health frameworks linking animal, human, and environmental health, increasing demand for diagnostics, vaccines, and field treatment solutions across wildlife populations. For instance, in April 2026, World Organization for Animal Health stated that nearly 75% of emerging infectious diseases originate in animals, strengthening focus on wildlife disease monitoring and intervention. In addition, the 2026 UN High-Level Meeting on Pandemic Prevention prioritized animal health systems as frontline defenses against future pandemics, accelerating procurement of surveillance tools, veterinary pharmaceuticals, and disease response infrastructure across wildlife health programs.

To learn more about this report, Download Free Sample Report

Moreover, the rising H5 avian influenza preparedness spending is increasing adoption of vaccines, monitoring equipment, rescue consumables, and captive wildlife healthcare services. Wildlife facilities, national parks, and conservation centers are receiving targeted funding for surveillance, quarantine, and emergency response capacity. For instance, in April 2026, the Australian government committed USD 35.9 million to strengthen H5 bird flu preparedness planning, including wildlife surveillance, disease spread analysis, and protection of threatened species. Furthermore, more than USD 100 million was allocated nationally for H5 response preparedness, while 21 facilities received additional funding to protect 26 threatened species in captivity. These investments are expanding procurement across the market.

In addition, growth in zoological institutions, rehabilitation centers, and wildlife referral hospitals is increasing continuous demand for pharmaceuticals, anesthesia systems, monitoring devices, and specialized veterinary care. The captive facilities require routine disease management, emergency care, surgical intervention, and preventive vaccination programs for mammals, birds, reptiles, and aquatic species. For instance, in 2025-2026, multiple regions expanded wildlife hospital infrastructure to improve emergency response and specialized treatment capacity, particularly for threatened and rescued species. Furthermore, institutions are increasing procurement of critical care consumables, rescue equipment, and research tools for rehabilitation and conservation programs. This expansion of organized wildlife care facilities is creating sustained long-term demand across the market, particularly within captive facility end users.

To learn more about this report, Download Free Sample Report

Market Dynamics

The wildlife health market is experiencing steady growth, driven by increasing awareness of biodiversity conservation, rising zoonotic disease risks, and expanding investments in wildlife healthcare infrastructure. In addition, growing surveillance of zoonotic diseases under the One Health framework has increased demand for advanced diagnostics, vaccines, pharmaceuticals, and health monitoring solutions to prevent disease transmission between wildlife, livestock, and humans. In addition, governments and international organizations are increasing funding for avian influenza preparedness, wildlife disease surveillance, and conservation programs, supporting the adoption of specialized veterinary products and technologies.

The expansion of wildlife rehabilitation centers, zoos, sanctuaries, and rescue facilities is fueling demand for medical equipment, critical care consumables, and emergency veterinary services. Furthermore, technological advancements in portable diagnostics, telemetry, wearable sensors, and remote health monitoring are improving disease detection and treatment outcomes in both captive and free-ranging wildlife. In addition, increasing collaborations among conservation agencies, research institutions, and veterinary organizations are strengthening wildlife health management, creating favorable conditions for sustained market growth over the forecast period.

Market Characteristics & Concentration

The wildlife health industry is fragmented due to the presence of global animal health companies, specialty veterinary suppliers, diagnostic firms, and regional wildlife care providers. In addition, large players dominate vaccines, pharmaceuticals, and diagnostics, while niche companies serve anesthesia, rehabilitation, and exotic animal care. Institutional procurement strongly influences competitive positioning.

The wildlife health sector shows moderate to high innovation, particularly in portable diagnostics, wildlife-safe vaccines, anesthesia systems, remote monitoring devices, and disease surveillance platforms. Institutions are adopting PCR-based diagnostics, wearable health trackers, and GIS-linked monitoring systems. Innovation is strongest in captive facilities and research institutions managing endangered species, zoonotic risks, and rehabilitation-intensive treatment environments.

To learn more about this report, Download Free Sample Report

M&A activity remains moderate, with larger veterinary health companies expanding through partnerships, minority investments, and regional acquisitions rather than large-scale consolidation. Companies focus on strengthening wildlife and exotic animal care capabilities through specialty clinics, diagnostics expansion, and pharmaceutical access. Strategic collaborations with zoos, wildlife hospitals, and conservation agencies are increasingly common across major regions.

Regulatory impact is high due to strict controls over wildlife treatment, species protection, pharmaceutical usage, and disease reporting. Governments and international bodies such as WOAH require surveillance, vaccination protocols, and outbreak reporting for zoonotic diseases and endangered species management. Veterinary interventions often require wildlife permits, biosafety compliance, and conservation authority approvals across countries.

Product expansion is increasing across anti-infectives, parasiticides, wildlife vaccines, anesthesia devices, and health monitoring equipment. Manufacturers are developing species-specific formulations and field-compatible equipment for rescue, transport, and rehabilitation settings. Growth in zoonotic surveillance is also increasing demand for diagnostic kits, portable instruments, and wildlife disease management software across institutional end users.

Regional expansion is rising across Asia Pacific, Africa, and Latin America due to biodiversity concentration, zoonotic disease risks, and growing conservation funding. Companies are increasing distributor networks and direct institutional supply to wildlife sanctuaries, zoos, and government agencies. North America and Europe continue leading in specialized diagnostics, advanced equipment, and research-driven wildlife health infrastructure.

Analyst Perspective

The wildlife health market is gaining momentum as global conservation priorities intersect with growing concerns over zoonotic disease transmission, biodiversity loss, and ecosystem sustainability. In addition, increasing awareness following recent pandemics has highlighted the critical link between wildlife health surveillance and human public health, prompting governments, NGOs, and research institutions to invest heavily in disease monitoring, vaccination programs, and habitat-based health interventions. In addition, advances in diagnostic technologies, including molecular testing and remote biotelemetry, are enabling earlier detection of pathogens in wild populations, while collaborative "One Health" frameworks are fostering integrated approaches across veterinary, environmental, and medical sciences. Furthermore, rising funding from international conservation bodies, coupled with increasing private-sector involvement in eco-tourism and wildlife rehabilitation, is further propelling market expansion. In addition, emerging economies with rich biodiversity are becoming focal points for research and intervention programs, supported by growing regulatory emphasis on wildlife trade monitoring and habitat protection. Thus, the market depicts a shift toward proactive, science-driven wildlife management, balancing ecological preservation with global health security imperatives.

Animal Insights

Based on animal, the mammals segment led the market with the largest revenue share of 46.0% in 2025 due to its high disease burden, greater veterinary intervention requirements, and strong conservation focus across captive and free-ranging populations. Species such as elephants, lions, tigers, bears, deer, rhinoceros, wolves, and primates require frequent treatment for infections, injuries, reproductive health, parasitic infestations, and immobilization during rescue or relocation. Similarly, large mammals also receive significant attention in zoos, safari parks, and rehabilitation centers, increasing routine healthcare demand. Furthermore, anti-poaching rescue operations and endangered species conservation programs contribute to sustained pharmaceutical, vaccine, and equipment utilization across this segment.

The birds segment is expected to witness the fastest CAGR over the forecast period, due to rising concerns regarding avian influenza, Newcastle disease, habitat-related injuries, and migratory disease transmission. Governments are increasing surveillance and preventive care for wild birds, particularly waterfowl, cranes, parrots, vultures, and raptors, due to their role in zoonotic disease spread. Captive breeding programs and rehabilitation centers are also increasing veterinary interventions for threatened avian species. Furthermore, H5 bird flu preparedness programs across Australia, Europe, and Asia are increasing demand for diagnostics, vaccines, rescue consumables, and emergency treatment services, supporting rapid segment growth.

Product Insights

Based on product, the pharmaceuticals segment led the market with the largest revenue share of 42.8% in 2025. This can be attributed to high and continuous demand for anti-infectives, parasiticides, analgesics, sedatives, and supportive therapies across mammals, birds, reptiles, and aquatic species. Wildlife rescue, rehabilitation, disease outbreak control, and captive management require frequent therapeutic intervention, particularly for infections, injuries, immobilization, and post-surgical recovery. Anti-infectives and parasiticides remain widely used across zoos, sanctuaries, and government wildlife programs. Increasing zoonotic disease surveillance and emergency treatment protocols are further increasing pharmaceutical procurement. In addition, species-specific formulations and broader field treatment applications continue supporting segment dominance globally.

The others segment is the fastest growing segment due to increasing adoption of wildlife health management software, disease surveillance platforms, GIS-based monitoring systems, and conservation database solutions. Governments, research institutions, and wildlife organizations are strengthening digital monitoring of disease outbreaks, migration patterns, treatment records, and species conservation programs. In addition, growing focus on One Health frameworks and zoonotic disease prevention is increasing demand for integrated wildlife tracking and reporting systems. Furthermore, real-time monitoring platforms improve outbreak response efficiency and field coordination. Rising investments in wildlife surveillance infrastructure across Asia Pacific, North America, and Australia are accelerating segment expansion.

Sales Channel Insights

Based on sales channel, the direct sales segment led the market with the largest revenue share of 60.4% in 2025. The segment’s growth is influenced by large-volume procurement by zoos, wildlife sanctuaries, government forest departments, national parks, and conservation agencies. Manufacturers directly supply pharmaceuticals, vaccines, anesthesia equipment, and critical care consumables to institutional buyers requiring customized contracts, consistent inventory, and regulatory compliance. This model improves procurement efficiency for large wildlife health programs involving disease surveillance, vaccination campaigns, and rehabilitation operations. Furthermore, direct purchasing supports better product traceability and faster emergency supply access during outbreaks such as avian influenza or zoonotic disease events, strengthening its market leadership globally.

The distributors/GPO sales are expected to grow at the fastest CAGR due to increasing cost optimization and procurement standardization across wildlife hospitals, sanctuaries, veterinary institutions, and regional conservation networks. Group purchasing organizations allow multiple facilities to procure pharmaceuticals, diagnostics, and equipment in bulk at lower negotiated prices, improving affordability for smaller institutions. This model is gaining adoption in developing regions where budget constraints affect wildlife healthcare access. Additionally, distributors improve product availability in remote areas, supporting field rescue operations and expanding veterinary coverage across fragmented wildlife care systems.

End Use Insights

Based on end-use, the captive facilities segment led the market with the largest revenue share of 52.2% in 2025, driven by continuous veterinary care requirements across zoos, aquariums, rescue centers, and rehabilitation facilities where wildlife remains under direct human supervision. These facilities require regular diagnostics, preventive vaccination, anesthesia support, surgery, nutritional monitoring, and disease management across multiple species. High-value endangered animals and breeding populations require advanced and routine medical intervention, increasing product consumption across pharmaceuticals, equipment, and diagnostics. Furthermore, strict welfare standards and regulatory compliance in captive settings drive consistent investment in specialized veterinary infrastructure, supporting the segment’s dominant market position.

To learn more about this report, Download Free Sample Report

The others segment is expected to grow fastest over the forecast period, due to increasing wildlife healthcare activities across national parks, forest departments, sanctuaries, and non-governmental conservation organizations. These end users are expanding disease surveillance, rescue missions, anti-poaching medical response, and habitat-based vaccination programs for free-ranging wildlife populations. Government funding for zoonotic disease control and biodiversity protection is increasing veterinary product utilization in field conditions. In addition, H5 avian influenza preparedness and rabies control programs are strengthening demand for diagnostics, vaccines, monitoring equipment, and emergency treatment supplies across non-captive wildlife management systems.

Regional Insights

North America dominated the wildlife health market with the largest revenue share of 30.4% in 2025. This large share can be attributed to strong wildlife disease surveillance, advanced veterinary infrastructure, zoonotic outbreak preparedness, and high spending by zoos, rehabilitation centers, and research institutions. Competitive activity is led by Zoetis, IDEXX Laboratories, and specialty wildlife diagnostic providers. In addition, regulatory oversight is strong through the U.S. Department of Agriculture, U.S. Fish and Wildlife Service, and wildlife disease reporting systems supporting zoonotic control, vaccination, and treatment approvals.

To learn more about this report, Download Free Sample Report

U.S. Wildlife Health Market Trends

The wildlife health market in the U.S. held the largest share in the North America region in 2025, owing to federal funding for wildlife disease preparedness, expansion of university-led wildlife health programs, and rising use of advanced diagnostics for chronic wasting disease, avian influenza, and rabies surveillance. In addition, national wildlife rehabilitation networks and veterinary teaching hospitals are increasing demand for specialized pharmaceuticals, pathology testing, and emergency treatment equipment.

The wildlife health industry in Canada is supported by the country’s vast biodiversity and strong emphasis on conservation and disease surveillance across remote and protected ecosystems. Government-led initiatives, collaborations with research institutions, and active monitoring of zoonotic diseases such as chronic wasting disease and avian influenza are key growth drivers. Additionally, Canada’s well-established veterinary infrastructure and increasing funding for wildlife rehabilitation centers and environmental protection programs contribute to the demand for advanced diagnostics, vaccines, and monitoring solutions. The integration of technology such as satellite tracking and data analytics in wildlife management further strengthens market expansion.

Europe Wildlife Health Market Trends

The wildlife health industry in Europe is identified as a lucrative region, driven by biodiversity conservation funding, avian influenza monitoring, wildlife rehabilitation programs, and strong One Health adoption across member countries. Some of the players include Boehringer Ingelheim International GmbH, Virbac, and regional wildlife care providers that are boosting market growth. Regulatory compliance is governed by European Medicines Agency, national veterinary authorities, and wildlife protection laws covering veterinary drug approvals, endangered species treatment, and disease surveillance obligations.

The wildlife health industry in UK held the largest share in 2025, due to increasing investment in wildlife rescue hospitals, marine wildlife rehabilitation, and urban biodiversity health management. Growing attention to badger tuberculosis, wild bird influenza monitoring, and hedgehog conservation programs is increasing veterinary intervention needs. Specialist referral centers are also expanding ophthalmology, surgery, and avian care services.

The wildlife health industry in Germany is driven by stringent environmental regulations and a proactive approach toward biodiversity conservation within highly managed ecosystems. The country’s focus on preventing disease transmission between wildlife and livestock, specifically African swine fever, has accelerated investments in surveillance and diagnostic capabilities. Strong collaboration between governmental bodies, academic institutions, and veterinary organizations supports continuous research and innovation. Moreover, increasing awareness regarding ecological balance and wildlife welfare, coupled with funding from European environmental programs, enhances the adoption of advanced veterinary healthcare solutions.

Asia Pacific Wildlife Health Market Trends

Asia Pacific wildlife health industry is expected to grow at the fastest CAGR over the forecast period.The anticipated to rising zoonotic disease outbreaks, government wildlife protection programs, and expanding zoo and sanctuary infrastructure across India, China, Australia, and Southeast Asia. Competitive activity is increasing through regional distributors and global players such as Virbac and Zoetis. Regulatory systems involve forest departments, veterinary authorities, and national disease control frameworks managing wildlife rescue, vaccination approvals, and cross-border disease monitoring.

The industry for wildlife health in India is witnessing notable growth due to expansion of wildlife rescue centers, elephant and big cat conservation programs, and stronger veterinary intervention in forest reserves and national parks. Government-led vaccination campaigns for rabies and disease control in free-ranging wildlife are increasing pharmaceutical demand. Rising private investment in exotic and wildlife veterinary services further supports adoption.

The wildlife health industry in Thailand is fueled by its rich wildlife diversity and the growing importance of eco-tourism and conservation efforts. The presence of numerous national parks and wildlife sanctuaries has increased the need for disease monitoring, rehabilitation services, and preventive healthcare measures. Government initiatives and partnerships with international conservation organizations play a crucial role in strengthening veterinary services for wild animals. Additionally, the rising risk of zoonotic diseases due to close human-wildlife interaction, along with expanding rescue and rehabilitation facilities, is driving demand for vaccines, diagnostics, and treatment solutions.

Latin America Wildlife Health Market Trends

The wildlife health industry in Latin America is driven by large wildlife populations, increasing zoonotic disease monitoring, biodiversity conservation programs, and rising government attention to forest and wildlife health management. Competitive participation remains moderate, led by regional veterinary suppliers and international firms expanding through distributors. Regulatory oversight is managed by environmental ministries, veterinary public health agencies, and wildlife conservation laws controlling treatment protocols, disease surveillance, and pharmaceutical access for protected and endangered wildlife species.

Brazil wildlife health industryis gaining momentum due to Amazon biodiversity protection programs, increasing wildlife rescue linked to deforestation and wildfires, and stronger zoonotic surveillance for primates and wild birds. Veterinary support for illegal wildlife trade rescues and rehabilitation centers is increasing demand for anesthesia systems, anti-infectives, and diagnostic testing across conservation facilities.

Middle East & Africa Wildlife Health Market Trends

Wildlife health market in MEA is advancing, due to wildlife tourism, conservation reserve expansion, transboundary disease risks, and increasing veterinary support for captive and free-ranging species. Competitive activity is growing through imported veterinary products and partnerships with global animal health companies. Regulatory control is handled by ministries of environment, veterinary authorities, and conservation agencies focusing on disease reporting, wildlife movement permits, vaccination campaigns, and protected species treatment compliance across national parks and reserves.

South Africa wildlife health industry is growing due to high-value wildlife conservation for safari reserves, anti-poaching medical interventions, and translocation programs for rhinos, elephants, and big cats. Wildlife capture and relocation activities require frequent sedatives, anesthesia systems, and monitoring equipment. Government-backed disease surveillance for foot-and-mouth disease and avian outbreaks further increases demand.

The wildlife health industry in Saudi Arabia is gaining traction due to increasing government focus on environmental sustainability and biodiversity preservation. Efforts to protect endangered species and restore natural habitats have led to the establishment of wildlife reserves and conservation programs, creating demand for veterinary care and monitoring systems. The country’s arid climate and unique ecosystem necessitate specialized healthcare solutions for wildlife species. Furthermore, growing investments in research, along with collaborations with international conservation bodies, are supporting the adoption of advanced diagnostic tools and disease management practices.

Key Wildlife Health Company Insights

The wildlife health industry is fragmented, with presence of large numbers of global animal health companies and specialized veterinary suppliers competing across pharmaceuticals, diagnostics, anesthesia, and rehabilitation equipment. Key participants include Zoetis, Boehringer Ingelheim International GmbH, Virbac, IDEXX Laboratories, and Wedgewood Pharmacy. Large players hold stronger shares in vaccines, diagnostics, and anti-infectives, while niche firms such as Jorgensen Laboratories and Hallowell EMC serve specialty care segments.

Key Wildlife Health Companies:

The following key companies have been profiled for this study on the wildlife health market.

• Zoetis

• Boehringer Ingelheim International GmbH

• Tecnovax

• Jorgensen Laboratories.

• WEDGEWOOD PHARMACY

• Hallowell EMC

• NexGen Pharmaceuticals.

• Virbac

• IDEXX Laboratories

• Avian & Exotic Animal Clin Path Labs

Recent Developments

• In March 2026, World Veterinary Association and Action for Animal Health recommended stronger investment in animal health systems for the UN High-Level Meeting on Pandemic Prevention. This accelerates funding for veterinary services, vaccines, diagnostics, and workforce development in the market.

• In February 2026, the Izaak Walton League of America highlighted that zoonotic diseases cause nearly 2.5 billion illnesses annually, strengthening focus on wildlife hospitals and One Health surveillance. This increases demand for diagnostics, vaccines, and veterinary treatment systems across the market.

• In in March 2025, International Livestock Research Institute, World Organization for Animal Health, and partners introduced a new wildlife health operational framework integrating wildlife into One Health systems. This supports higher adoption of surveillance tools, pharmaceuticals, and coordinated disease management solutions globally.

Global Wildlife Health Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the wildlife health market report based on product, animal, end use, sales channel, and region.

• Animal Outlook (Revenue, USD Million, 2021 - 2033)

  • Mammals

  • Birds

  • Aquatic Species

  • Reptiles

  • Amphibians

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceuticals

    • Anti-infectives

    • Parasiticides

    • Analgesics

    • Sedatives

    • Others

  • Vaccines

  • Diagnostics

    • Consumables, reagents and kits

    • Instruments and devices

  • Equipment & Disposables

    • Critical Care Consumables

    • Anesthesia Equipment

    • Health Monitoring Equipment

    • Rescue & Resuscitation Equipment

    • Research Equipment

    • Others

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Captive Facilities

  • Research Institutions

  • Others

• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Direct Sales

  • Distributors/GPO Sales

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • UAE

    • Saudi Arabia

    • Kuwait

    • Qatar

    • Oman

Research Methodology

The wildlife health market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with wildlife health segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations